🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1b Study to Assess the Safety, Tolerability, Pharmacokinetics, and ...
Status
Completed
Location
Phoenix, AZ
Start Date
2025-02-12
Trial ID
NCT07484074
This study will evaluate the efficacy, safety, durability, and pharmacokine...
Status
Completed
Location
Retinal Research Institute, LLC
Start Date
2019-02-19
Trial ID
NCT03823287
Treatments Being Tested
This randomized controlled trial compares two techniques for eyelid retract...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06
Trial ID
NCT07481500
Treatments Being Tested
Background: Age-related macular degeneration (AMD) is a common eye disease ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07744204
Treatments Being Tested
The study is designed for multi-center,randomized,double-masked,active-cont...
Status
Active Not Recruiting
Location
Shanghai General hospital
Start Date
2025-04-24
Trial ID
NCT06908876
This was a Phase II, multicenter, randomized, active comparator-controlled,...
Status
Completed
Location
Retinal Consultants of Arizona
Start Date
2017-01-27
Trial ID
NCT03038880
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, Pharmaco...
Status
Recruiting
Location
Associated Retina Consultants - Peoria - DocTrials - PPDS
Start Date
2026-04-21
Trial ID
NCT07425522
The purpose of this Phase 2 study is comprised of two groups to evaluate th...
Status
Completed
Location
California Retina Consultants
Start Date
2023-05-16
Trial ID
NCT05681884
Treatments Being Tested
Home optical coherence tomography- guided treatment versus treat and extend...
Status
Active Not Recruiting
Location
Kent W. Small, MD, AMC
Start Date
2023-11-09
Trial ID
NCT05904028
Neovascular Age-Related Macular Degeneration (nAMD) is one of the main caus...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07088445
Treatments Being Tested